By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer reported after the close of the market Thursday that its fourth-quarter revenues increased 15 percent, or 6 percent organically, over the fourth quarter of 2010.

The Waltham, Mass.-based analytical tools firm brought in total revenues of $540.2 million for the three-month period ended Jan. 1, 2012, compared to $470 million for the fourth quarter of 2010. It beat analysts' consensus estimate for revenues of $537.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.